|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 9.000 SEK | +2.16% |
|
+0.67% | -33.33% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 99.64M 10.36M 8.93M 8.42M 7.67M 14.33M 978M 14.44M 38.67M 500M 38.89M 38.04M 1.64B | P/E 2026 * |
-2.99x | P/E 2027 * | -2.49x |
|---|---|---|---|---|---|
| Enterprise Value | 91.64M 9.52M 8.22M 7.74M 7.05M 13.18M 900M 13.28M 35.57M 460M 35.77M 34.98M 1.51B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Vivesto AB
| 1 day | +2.16% | ||
| 1 week | +0.67% | ||
| Current month | +1.81% | ||
| 1 month | +7.40% | ||
| 3 months | -7.22% | ||
| 6 months | +8.70% | ||
| Current year | -33.33% |
| 1 week | 8.72 |  | 9 |
| 1 month | 8.41 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 2023-01-22 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 2026-06-30 |
| Chief Tech/Sci/R&D Officer | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 2022-05-24 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 2019-09-25 |
Pål Ryfors
BRD | Director/Board Member | 43 | 2022-05-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/25/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 3/24/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 12/20/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | +0.67% | -60.95% | -57.14% | 10.17M | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 654B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 459B | |
| +0.49% | -5.19% | +33.28% | +34.59% | 343B | |
| +0.27% | +3.26% | +29.76% | +46.97% | 307B | |
| +0.12% | -2.11% | +0.60% | +11.93% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.64% | 202B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.87% | -1.38% | +20.98% | +40.67% | 367.16B | |
| Weighted average by Cap. | +0.63% | -1.31% | +38.85% | +67.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.22M -2.78M -2.62M -2.39M -4.46M -304M -4.49M -12.03M -156M -12.1M -11.83M -511M | -40M -4.16M -3.59M -3.38M -3.08M -5.75M -393M -5.8M -15.52M -201M -15.61M -15.27M -660M |
| Net Debt | -8M -831K -717K -676K -616K -1.15M -78.55M -1.16M -3.1M -40.16M -3.12M -3.05M -132M | -17M -1.77M -1.52M -1.44M -1.31M -2.45M -167M -2.46M -6.6M -85.34M -6.63M -6.49M -280M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | SEK 9.000 | +2.16% | 1,982 |
| 26-09-01 | SEK 8.810 | -0.34% | 9,148 |
| 26-08-31 | SEK 8.840 | +1.03% | 5,458 |
| 26-08-28 | SEK 8.750 | -2.67% | 8,921 |
| 26-08-27 | SEK 8.990 | +0.56% | 8,721 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
